Date & Location: Friday, April 11, 2025, 7:30 AM – 2:00 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA
Target Audience
Specialties – Cardiology, Emergency Medicine, Endocrinology & Metabolism, Family / General Medicine, Internal Medicine, Preventive Medicine
Professions – Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Physician, Physician Assistant
Overview
The 19th Annual Women and Ischemic Heart Disease Symposium will explore sex- and gender-specific issues in womens cardiovascular health, including key topics such as Understanding and Treating MINOCA in 2025, Sex Differences in Stroke Management & Prevention, and Identifying Cardiovascular Risk in Pregnancy. Attendees will also engage in debates on critical topics, including CVD Risk Assessment Tools for Young Women and the merits of Invasive vs. Noninvasive Diagnosis for Coronary Microvascular Dysfunction (CMD). In addition, the symposium will cover heart failure management in women, from GDMT to VAD to Transplant, and provide a detailed discussion of Spontaneous Coronary Artery Dissection (SCAD) cases. Finally, the intersection of Coronary Microvascular Dysfunction and HFpEF will be explored in depth. The purpose of this conference is to close the knowledge gaps of healthcare professionals regarding gender- and sex-specific differences in cardiovascular disease, the impact these differences have on treatment options, and the importance of identifying women at risk for cardiovascular disease. The symposium will provide the most current evidence-based treatment strategies for optimizing care for women with ischemic heart disease.
Objectives
Recognize the importance of risk assessment in young women and the limitations of currently available risk assessment tools
Understand the noninvasive and invasive options for assessment of women with presumed INOCA
Recognize sex differences in stroke
Provide care and treatment to women at risk for cardiovascular disease during pregnancy
Explore new approaches and therapies for SCAD and MINOCA
Effectively communicate and collaborate with healthcare team members to optimize the diagnosis, treatment, and management of women with ischemic heart disease.
The 19th Annual Women and Ischemic Heart Disease Symposium 2025 is designed for physicians across several specialties who are involved in cardiovascular care, particularly with a focus on sex- and gender-specific approaches. The key physician audiences include:
Cardiologists
Emergency medicine physicians
Endocrinologists
Family and general medicine practitioners
Internal medicine specialists
Preventive medicine physicians
The symposium emphasizes evidence-based strategies for diagnosing and managing ischemic heart disease in women, covering topics like MINOCA, SCAD, cardiovascular risk in pregnancy, and sex differences in stroke prevention
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
April 11 Full Live.mp4
Agenda.pdf
Debate- CVD Risk Assessment Tools are Effective in Young Women.pdf
Debate- Invasive Diagnosis is Better than Noninvasive approach to CMD.pdf
Heart Failure in Women, from GDMT to VAD to Transplant.pdf
Identifying Cardiovascular Risk in Pregnancy.pdf
Keynote Lecture- Understanding and Treating MINOCA in 2025.pdf
Sex Differences in Stroke Management & Prevention.pdf
* Detail:
Friday, April 11, 2025
Registration and Check In/Exhibits
7:15AM – 8:00AM
Disclosure and CME Accreditation Information
7:55AM – 8:00AM
Welcome/Introduction and 11th Annual Linda Joy Pollin Women’s Heart Health Leadership Award: Recipient: Sharonne Hayes, MD
8:00AM – 8:10AM
C. Noel Bairey Merz, MD, FACC, FAHA, FESC
Sharonne N. Hayes, MD (Keynote Speaker)
Keynote Lecture: Understanding and Treating MINOCA in 2025
8:10AM – 8:50AM
C. Noel Bairey Merz, MD, FACC, FAHA, FESC (Moderator)
Sharonne N. Hayes, MDChair: C. Noel Bairey Merz, MD
Q&A
8:50AM – 9:00AM
Pre-Test
9:00AM – 9:10AM
C. Noel Bairey Merz, MD, FACC, FAHA, FESC
Sex Differences in Stroke Management & Prevention
9:10AM – 9:35AM
Ana Iribarren, MD (Moderator)
Shlee S. Song, MD
Q&A
9:35AM – 9:45AM
Identifying Cardiovascular Risk in Pregnancy
9:45AM – 10:10AM
Margo B Minissian, PhD (Moderator)
Rose Tompkins, MD
Q&A
10:10AM – 10:20AM
BREAK/EXHIBITS
10:20AM – 10:30AM
Debate: CVD Risk Assessment Tools are Effective in Young Women
10:30AM – 10:55AM
Margo B Minissian, PhD
Janet Wei, MD, FACC (Moderator)
Martha Gulati, MD
Q&A
10:55AM – 11:05AM
Heart Failure in Women, from GDMT to VAD to Transplant
11:05AM – 11:30AM
Andriana Nikolova, MD, PhD (Moderator)
Michelle Kittleson, MD, PhD
Q&A
11:30AM – 11:40AM
LUNCH/EXHIBITS
11:40AM – 12:20PM
10 min Stretch hosted by Cedars-Sinai Cardiac Rehab led by Debbie Potyk
12:20PM – 12:30PM
Debate: Invasive Diagnosis is Better than Noninvasive approach to CMD
12:30PM – 12:55PM
Martha Gulati, MD (Moderator)
Bruce Samuels, MD
Alan C. Kwan, MD
Q&A
12:55PM – 1:05PM
Cases: Spontaneous Coronary Artery Dissection (SCAD): Diagnostic and Therapeutic Approaches
1:05PM – 1:15PM
C. Noel Bairey Merz, MD, FACC, FAHA, FESC (Moderator)
Ana Iribarren, MD
Q&A
1:15PM – 1:25PM
The Intersection of Coronary Microvascular Dysfunction and HFpEF
1:25PM – 1:50PM
Janet Wei, MD, FACC
Valentina Obreja, NP (Moderator)
Q&A
1:50PM – 2:00PM





Reviews
There are no reviews yet.